Insider · CIK 0001822371
Dennis Patrick Molnar
Files at APMD (Apnimed, Inc.). First filing -, latest -.
In brief
Dennis Patrick Molnar files SEC Form 4 as president at APMD (Apnimed, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dennis Patrick Molnar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Class A Common Stock | -58,014 | - | - | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Common Stock | +58,014 | - | - | 58,014 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -330,210 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +330,210 | $0.00 | $0 | 330,210 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,240 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +42,240 | $0.00 | $0 | 42,240 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -148,788 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +148,788 | $0.00 | $0 | 148,788 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -37,064 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,064 | $0.00 | $0 | 37,064 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -28,539 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +28,539 | $0.00 | $0 | 28,539 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -37,064 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy) Stock Option (Right to Buy)derivative | +37,064 | $0.00 | $0 | 37,064 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,231 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,231 | $0.00 | $0 | 12,231 | Aug 3, 2026 |
| Jul 30, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +55,596 | $0.00 | $0 | 55,596 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,596 | $0.00 | $0 | 0 | Aug 3, 2026 |
| Aug 3, 2026 | APMD Apnimed, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +55,596 | $0.00 | $0 | 55,596 | Aug 3, 2026 |
Questions about Dennis Patrick Molnar
Answered from the filings on this page, as of the latest one.
Is Dennis Patrick Molnar buying or selling?
Dennis Patrick Molnar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dennis Patrick Molnar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis Patrick Molnar has 0.
Where does Dennis Patrick Molnar file Form 4?
Dennis Patrick Molnar has filed Form 4 at APMD (Apnimed, Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.